Vol.

No.

December 03, 2021Dec 03, 2021

DOWNLOAD THE PDF

Cover Story

Cancer centers establish DEI Network as NCI issues CCSG guidelines to enhance diversity in the oncology workforce

By Matthew Bin Han Ong

Every cancer center seeking to obtain (or keep) an NCI designation will soon have to present a plan for increasing the diversity of their faculty and workforce.

Conversation with The Cancer Letter Health Equity

DEI Network founders: Let’s work together to increase diversity across all cancer centers in America

By Matthew Bin Han Ong

Regulatory News

FDA cancels second ODAC in a row as two accelerated approval drugs are yanked by sponsors (and one still dangles)

By Alice Tracey

Auction lot No. 3: E. Donnall Thomas’s Nobel Prize medal (min. bid: $250,000)

By Alice Tracey

Cancer History Project Conversation with The Cancer Letter Free

What the NCI cancer centers program looked like in 1975
Previously unpublished “memos for the record” by program’s first leader, John Yarbro, tell all

By Paul Goldberg

Free In the Archives

A history of the clinical cancer program at Yale

In Brief

Richard Fisher steps down from leadership roles at Fox Chase Cancer Center

Scott Lippman named vice chancellor, transitioning from UCSD Moores director role

Robert Califf receives support from 54 organizations to be commissioner of the FDA

Sylvester named WHO Collaborating Centre for Cervical Cancer Elimination

Tara Henderson to lead pediatric cancer, blood disease programs at UChicago

Paolo Caimi, Kaleena Chilcote, and Joel Saltzman named to new positions at Cleveland Clinic Cancer Center

Jaye Gardiner awarded $225,000 Black in Cancer postdoctoral fellowship for pancreatic cancer research

Bristol Myers Squibb Foundation establishes first cohort of the Diversity in Clinical Trials Career Development Program

Orin Bloch to co-lead UC Davis Cancer Center’s Biomedical Technology Program

Perlmutter Cancer Center opens transplantation and cellular therapy center for blood cancers

Lee Gerson joins Steeplechase Cancer Center at RWJUH Somerset as thoracic surgeon

ACS and International Association of Fire Fighters form partnership to fight occupational cancer

Funding Opportunities

AACR and Pelotonia announce scientific achievement awards for women’s cancers, funded by The Victoria’s Secret Global Fund for Women’s Cancers

Clinical Roundup

Yale Cancer Center researchers link ALK receptor structure to targets for cancer treatment

IMGN853 linked to improved outcomes in (FRα)-high platinum-resistant ovarian cancer

Fox Chase’s Suzanne Miller develops special edition of Translational Behavioral Medicine

Drugs & Targets

FDA approves Fyarro for malignant perivascular epithelioid cell tumor

FDA approves Darzalex Faspro, Kyprolis, and Dexamethasone for multiple myeloma

FDA approves Cytalux for identifying malignant ovarian cancer lesions

FDA grants orphan drug designation to UV1 cancer vaccine in metastatic melanoma

European Commission approves Keytruda plus Lenvima for patients with certain types of endometrial carcinoma

NCI Trials

NCI Trials for December 2021

The National Cancer Institute approved the following clinical research studies last month.

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 52 | Issue 05 - February 06, 2026